Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chemotherapy is Scopus-indexed (Q2, CiteScore 3.6), WoS SCIE. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 0009-3157Verify ISSN ↗1421-9794Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 178 / 361 | 50th | Q2 |
| Pharmacology (medical) | 148 / 278 | 46th | Q3 |
| Oncology | 237 / 428 | 44th | Q3 |
| Pharmacology | 196 / 328 | 40th | Q3 |
| Drug Discovery | 105 / 161 | 35th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1960–present, best quartile Q2, CiteScore 3.6.
Chemotherapy is Q2 in Infectious Diseases (rank 178 of 361), Q3 in Pharmacology (medical) (rank 148 of 278) and Q3 in Oncology (rank 237 of 428), by CiteScore 2025. It is ranked in 5 subject areas in all.
Chemotherapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.6, which places it in quartile Q2 at the 50th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.442, quartile Q3, with an H-index of 64.
Chemotherapy is published by S. Karger AG. Its print ISSN is 0009-3157 and its online ISSN is 1421-9794.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Chemotherapy has an h-index of 80 and a 2-year mean of 1.78 citations per paper (OpenAlex). Its Scopus CiteScore is 3.6, quartile Q2. On 2-year citations it ranks #177 of 354 Scopus journals in Infectious Diseases.
Chemotherapy published 10 papers in 2025; its busiest recent year was 2018 with 54. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2022–2026), authors are most often from China (24.7%), Italy (23.4%) and Japan (13.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.